News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

BioSpace News - All
Nearly 500 Amgen (AMGN) Staffers to be Reassigned, Relocated or Laid Off in Restructuring 3/27/2017
Johnson & Johnson (JNJ)'s $100,000 Anti-Burnout Program for Top Execs 3/27/2017
Former Baxalta (BXLT) CEO to Helm Struggling Alexion (ALXN) 3/27/2017
These Two Drugmakers Have Even More Debt Than Valeant (VRX) 3/27/2017
Filings Reveal Concert Pharma (CNCE) Spurned $250 Million Buyout Offer From Vertex (VRTX) in November 2016 3/27/2017
GE Healthcare to Invest $500 Million and Hire 5,000 Software Engineers 3/27/2017
Media Mogul Rupert Murdoch Dumps $125 Million Theranos Stake for $1 3/27/2017
This Colorado Pharma May Not Have Enough Cash to Last 2017 3/24/2017
Theranos CEO Gives Up Own Shares to Investors to Avoid Being Sued 3/24/2017
Google (GOOG)'s Mysterious Biotech Calico Forms a Rare Deal With C4 Therapeutics 3/24/2017
Drug Giant Amgen (AMGN) to Create Hundreds of New Jobs in Florida 3/24/2017
Google (GOOG)'s Verily Employees Make Themselves at Home at Onyx (AMGN)'s Former HQ 3/24/2017
How This New Jersey Biotech is Taking on Amgen (AMGN) 3/24/2017
Rumor Alert: Sanofi (SNY) Close to Scooping Up This Massachusetts Biotech in $1 Billion+ Deal 3/24/2017
Despite Recent Layoffs, Eli Lilly (LLY) to Invest $850 Million in U.S. Operations 3/24/2017
3 Biotechs the Super-Rich Regret Buying in 2017 (So Far) 3/24/2017
Biogen (BIIB)'s Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target 3/24/2017
Teva (TEVA) Backpedals on 6,000 Job Cuts, Says Figure is Too High 3/24/2017
MEDA to Shut Down Facility But Employees Could Land a Gig at Neighboring Akorn Pharma 3/24/2017
Boston's Paratek Pharma (PRTK) Expands Pennsylvania Operations With 30 Employees, Can Accommodate 100 3/24/2017
Bay Area's Ultragenyx (RARE) Tanks as Seizure Drug Flunks Phase II Test 3/23/2017
Why Struggling Bristol-Myers Squibb (BMY) Could Take Out This Danish Biotech in Major €500M Deal 3/23/2017
Turns Out Editas Medicine (EDIT)'s R&D Deal With Allergan (AGN) Could be Worth $1 Billion 3/23/2017
How Biogen (BIIB) Spinoff Bioverativ (BIVVV) and Its Hemophilia Med Could Make This Biotech Bleed 3/23/2017
5 Biotechs That Have Major Catalysts Coming in the Next 6 to 9 Months 3/23/2017
UCSF Heart Doctor Wary of Amgen (AMGN)-Paid Repatha Study 3/23/2017
Filing Shows Money Woes May Force NeuralStem to Halt Trials, Cease Operations or File for Bankruptcy 3/23/2017
5 Biotechs the Super-Rich Are Favoring in 2017 (So Far) 3/23/2017
Novartis AG (NVS)'s Phase III Drug for Heart Failure Bombs Trial 3/23/2017
Reverse Merger With Dare Bioscience Gives Cerulean (CERU) Execs a Parting Gift—Bonuses 3/23/2017
How This Drug Candidate Could be a Winner in Gilead (GILD)'s Pipeline 3/23/2017
How to Rework Your Resume to Make the Big Data Leap from Tech to Biotech 3/23/2017
4 Small-Cap Biotechs to Consider if Gilead (GILD) Isn’t Doing it For You 3/22/2017
Facebook Hiring Dozens for Secretive Division, Rumored to be Working on Brain-Scanning Technology and Other Med Device 3/22/2017
Intellia’s CEO Has Cambridge-Based Company Moving Forward on Positive in vivo Data 3/22/2017
Ex-Novartis AG (NVS) Exec to Take the Reins at Bay Area's Forty Seven on May 1 3/22/2017
Heat Biologics (HTBX) Rockets as Lung Cancer Med Hits Mid-Stage Goals 3/22/2017
Filings Reveal Alnylam (ALNY) CEO's Pay Dropped Almost 80% in 2016 3/22/2017
Former Celgene (CELG) Exec to Helm Cipher Pharma (DND.TO) 3/22/2017
Questions Arise Over This Bay Area Biotech CEO's Doctorate Degree and His Time at the University of Pennsylvania 3/21/2017
For Sale: Nektar Therapeutics (NKTR) Plans to License Hot New Opioid Drug 3/21/2017
Cerulean (CERU) to Slash More Than Half of Its Remaining Staff, Merge With SoCal Biotech 3/21/2017
Ex-GlaxoSmithKline (GSK) Scientists' Pulmocide Hauls in $30.4 Million 3/21/2017
Investors Squeal With Delight as Eli Lilly (LLY)'s Breast Cancer Combo Succeeds in Phase III, Faces Tough Competition from Pfizer (PFE) and Novartis AG (NVS) 3/21/2017
Trump Budget Would Double FDA Product Review Fees, Leading to Faster Drug Approvals 3/21/2017
Bay Area's CytomX (CTMX) Surges as Bristol-Myers Squibb (BMY) Signs Up for 8 More Projects With $200 Million Upfront in Deal Totaling $5 Billion 3/20/2017
Trump's Expected Policy Changes Have Propelled These 2 Biotechs to New Highs 3/20/2017
Fired U.S. Attorney Preet Bharara Was Investigating New HHS Chief Tom Price 3/20/2017
Why This Biotech Says It's Close to Curing the Type of Cancer That Killed Steve Jobs 3/20/2017
Biogen (BIIB) Faces Biggest One-Day Drop 3/20/2017
Crippled Bay Area Pharma Threshold (THLD) Rockets on Reverse Merger Deal With Molecular Templates 3/20/2017
The Hype Behind Massachusetts Biotech Corbus (CRBP)' Sole Pipeline Drug 3/20/2017
FDA Deals Another Blow to AstraZeneca PLC (AZN)'s Blood Drug 3/20/2017
Disappointment Hits as Amgen (AMGN)'s Repatha Prevents Heart Attacks, But Not Deaths 3/20/2017
Major Reorganization to Hit the NIH, Deep Cuts to Affect Thousands Under Trump Budget Plan 3/17/2017
This CRISPR Startup Co-Founded by a 30-Year-Old Just Nabbed $38 Million for Pig-to-Human Transplants 3/17/2017
How 3 Laid Off Employees Turned Pfizer (PFE)'s Discarded Compounds Into Novartis AG (NVS) Gold 3/17/2017
World's Smartest Billionaire Upped Position in This Bay Area Biotech 3/17/2017
Life Hack for Scientists: 9 Web-Savvy Tips to Get Your CV or Resume to the Top of an HR Search 3/17/2017
With Key Hire, Veritas Genetics Takes Leap Toward Affordable Genome Sequencing 3/17/2017
300 Employees Impacted as Teva (TEVA) to Shut Down or Sell Virginia Plant 3/16/2017
PTC Therapeutics (PTCT) Buys Marathon Pharma's Controversial $89,000-Per-Year DMD Drug for $190 Million 3/16/2017
Lawmakers Question the FDA's "Unusual" Approval of Marathon Pharma's Controversial Old DMD Drug 3/16/2017
Despite Expansion Overall, Roche Diabetes Care Lays Off 157 3/16/2017
Embattled Alexion (ALXN) Pink Slips 200+ Staffers in Restructuring 3/16/2017
Ex-Google (GOOG) Rock Star Decides to Raise $100 Million Biotech Venture Fund After All 3/16/2017
Meet the Teen Scientist Who Won Regeneron (REGN)'s Science Talent Search 2017 3/16/2017
AstraZeneca PLC (AZN) Steals Tesaro (TSRO)'s PARP Thunder With Phase III Ovarian Cancer Data 3/16/2017
Why Pfizer (PFE) Will Not Make Another Mega M&A Deal Anytime Soon 3/15/2017
3 Dazzling Biotechs Poised to Soar Even More 3/15/2017
GlaxoSmithKline (GSK)'s First Woman CEO Will Get a Smaller Paycheck Than (Male) Predecessor 3/15/2017
Bernie Sanders: Trump Must Stop Sanofi (SNY)'s Exclusive Zika Deal 3/15/2017
What a Gilead (GILD)-Incyte (INCY) Marriage Would Look Like 3/15/2017
Rumors Surface M&A-Desperate Gilead (GILD) is Nearing a Deal to Buy Incyte (INCY) 3/15/2017
Bay Area’s Dynavax (DVAX) Shifts Focus to Immune-Oncology, Cuts 40% of Staff 3/14/2017
2 Biotechs That Could Vanish by 2019 3/14/2017
It's Official: Trump Nominates Scott Gottlieb for Top FDA Job 3/14/2017
Ackman Is Finally Done With Valeant (VRX), Takes $2.8 Billion Loss and Will Step Down From Board 3/14/2017
FDA Demands Karyopharm (KPTI) Stop Enrollment of All Selinexor Trials 3/14/2017
Why an Acquisition of This CAR-T Biotech Makes Sense 3/14/2017
Shakeup at Intrexon (XON) as a Subsidiary is Created and an Ex-Pfizer (PFE) Exec Exits in Reorg 3/14/2017
A Win for venBio as Judge Hits Pause on Immunomedics (IMMU)'s $2 Billion Deal With Seattle Genetics (SGEN) 3/13/2017
Why This Biotech Has Amazon (AMZN)-Growth Potential 3/13/2017
3 Under-the-Radar Biotech Stocks to Check Out in March 3/13/2017
One Death in the HAVEN 1 Trial Complicates Roche (RHHBY)’s Entry into the Hemophilia A Market 3/13/2017
Troubled Cempra (CEMP) Looks for a Lifeline, Hires Morgan Stanley to Review Options 3/13/2017
Bay Area's Galena Biopharma  (GALE) Exploring Strategic Alternatives Just One Month After CEO Steps Down 3/13/2017
San Diego's Tocagen Goes for $86 Million IPO 3/13/2017
Boston Scientific (BSX) Commits to 10 More Years in SoCal Space, Plans to Hire 3/10/2017
Argos (ARGS) Cuts Staff by 38% After Devastating Phase III News 3/10/2017
9 Questionable Drugs Biotechs Are Submitting to the FDA in a Hail Mary Pass 3/10/2017
Trump's Pick for New FDA Head Getting Down to the Wire 3/10/2017
Painful Setbacks Lead Bristol-Myers Squibb (BMY) to Bring in a New R&D Chief 3/10/2017
This Bay Area Biotech is Being Wooed by Drug Giant Novo Nordisk A/S (NVO) 3/10/2017
C-Suite Shakeup: Novogen (NVGN) CEO North America, CSO and CFO Exit in Reorg 3/10/2017
3 Biotechs Under $5 With Jaw-Dropping Growth Potential 3/10/2017
Pfizer (PFE) Eyes $100 Million Expansion, New Jobs in North Carolina 3/10/2017
Oscar Winner Turned Pharma CEO: We’ll Prevent Genital Herpes 3/10/2017
Retrophin (RTRX) to Close Down Cambridge Operations, Cut Jobs in Consolidation Move 3/10/2017
Merck KGaA (MKGAF.PK) in Deep Talks to Sell Biosimilars Unit 3/10/2017
President Trump Tosses Tweet-Bomb at Drug Industry, Stocks Drop 3/9/2017
Former Millennium and FORUM Pharma CEO Resurfaces to Helm Massachusetts Biotech XTuit 3/9/2017
Breath Therapeutics Holding BV Spins Out of PARI Pharma With $46 Million and a Ready-to-Go Phase III Drug/Device Combo 3/9/2017
AstraZeneca PLC (AZN) Had 'Fake Doctor' Under Payroll in Australia 3/9/2017
Backed by Google (GOOG), Cambridge's Spero Nabs $51.7 Million Series C 3/8/2017
NantHealth (NH) Founder Patrick Soon-Shiong Calls Report on Fund Diversion 'Maliciously False' 3/8/2017
World's Richest Doctor Accused of Diverting Donations Back to His Own Companies 3/8/2017
Meet Mark Zuckerberg’s Man in the Lab at the Chan Zuckerberg Initiative 3/8/2017
Sanofi (SNY) Looking to Slap 'For Sale' Sign on Its European Generic Drug Biz, Deal Could Bring in $2.1 Billion 3/8/2017
Third Rock Ventures Quietly Launches Tango Therapeutics in Editas Medicine (EDIT)’s HQ 3/8/2017
The Elephant in the Room—Investors Pushing for Lower Pay for 1st Female GlaxoSmithKline (GSK) CEO 3/7/2017
8 Biotechs That Could Be Taken Out Soon 3/7/2017
Why Pharma Giant AstraZeneca PLC (AZN)'s Market Value Gained $3.8 Billion Last Month 3/7/2017
Amgen (AMGN) Files Trade Secret Action Against Bay Area's Coherus 3/7/2017
COO and First Employee of Editas Medicine (EDIT) to Exit, Effective March 31 3/7/2017
2 Tempting Biotech Stocks to Avoid Like Mad 3/7/2017
Why Ex-Mayor Peterson is Stepping Down From Eli Lilly (LLY) After 7 Years On the Job 3/7/2017
Chinese Billionaire's Biotech Hutchison China MediTech (Chi-Med) Shows Off Phase III Cancer Drug Data 3/6/2017
Biotech Guru's Roivant Sciences Could Soon Double Its Headcount in North Carolina 3/6/2017
Why This Alzheimer's Biotech May Not Live to See 2020 3/6/2017
Vertex (VRTX) Inks Deal Worth $250 Million for Concert Pharma (CNCE)'s Cystic Fibrosis Drug 3/6/2017
Filings Reveal Billionaire Super-Investor Stocked Up on These 2 Biotech Stocks 3/6/2017
Rumor Alert: Novartis AG (NVS) In Talks to Buy NASH Biotech GENFIT (ALGFT) 3/6/2017
Following Up on Bristol-Myers Squibb (BMY)'s Restructuring Plans, Company Makes Move to Shift 1,250 Workers Out of Hopewell Township Site 3/6/2017
Short Sellers Load Up on Pfizer (PFE) After Buyout Rumors 3/6/2017
Eurofins Starts $59 Million Expansion, Creates 350 Jobs 3/6/2017
Sanofi Pasteur (SASY.PA) Inks $645 Million RSV Deal With AstraZeneca PLC (AZN)'s MedImmune (AZN) 3/6/2017
This Technical Skill Wanted for Cancer Research Jobs 3/3/2017
9 Massachusetts Biotechs Facing Major FDA Decisions This Year 3/3/2017
Scientists, Here’s the Best Elevator Pitch to Sell Yourself to a Potential Employer 3/3/2017
Genentech (RHHBY) New Breast Cancer Cocktail Cuts Deaths in Phase III Study, Roche (RHHBY) Stock Soars 3/3/2017
Backed by Amazon (AMZN) and Big Names Like Bristol-Myers Squibb (BMY), Celgene (CELG) and Merck & Co. (MRK), Bay Area's GRAIL Banks $900 Million 3/3/2017
Juno (JUNO) Finally Drops Problem CAR-T Drug That Caused Deaths 3/3/2017
10 Biotechs With an Orphan Drug in Late-Stage Pipeline 3/3/2017
Novartis AG (NVS) Puts Cancer Hopes on 4 Star Scientists Poached From Harvard Last Year 3/3/2017
The Jackson Laboratory Seeks 60 Scientists Now in Connecticut to Tackle Some of Humankind’s Most Pressing Diseases With Precision 3/3/2017
6 Biotechs Facing Key FDA Decisions in March 3/2/2017
Why a Double-Digit Job Growth is Set to Hit This Biotech Hub 3/2/2017
Getting on the Short List: 6+ Tips for Life Science Research Assistant Job Applications 3/2/2017
Pfizer (PFE)'s Kansas Plant is 'Out of Control' and Puts Patients at Risk, Says the FDA 3/2/2017
Avoid These 3 Biotech Stocks Like the Plague 3/2/2017
Kite Pharma (KITE)'s CAR-T Blood Cancer Candidate Succeeds in Major Study 3/2/2017
Trump Takes Another Shot at the FDA's 'Slow And Burdensome' Approval Process 3/1/2017
Veloxis Pharma (VELO) to Shut Down New Jersey Office, Moving All Operations to North Carolina 3/1/2017
Exclusive: Janssen Pharmaceutical Just Came Clean on Drug Pricing Data 3/1/2017
Perrigo (PRGO) Cuts 750 Jobs, Sells MS Drug Royalties for $2.85 Billion and Loses CFO to Amgen (AMGN) 3/1/2017
The 5 Drug Giants That Could Snap Up a Struggling Bristol-Myers Squibb (BMY) 3/1/2017
Merck & Co. (MRK), Eli Lilly (LLY) Failure Puts Alzheimer's Drug Development Spotlight on Rival Genentech (RHHBY) 3/1/2017
Troubled Cempra (CEMP) Slashes 67% of Workforce 3/1/2017
Momenta (MNTA) to Become Neighbors With Biogen (BIIB), Ironwood (IRWD) in Kendall Square Next Year 2/28/2017
A Look Inside Takeda (TKPYY)'s Remarkable R&D Transformation 2/28/2017
Bayer (BAY)'s Job Cuts at Mission Bay Campus Leaves Room for New Bay Area Startups 2/28/2017
CRISPR/Cas9 Startup Exonics Therapeutics Launches in Boston 2/28/2017
Biotech Vets Launch Arrakis Therapeutics With $38 Million and Will be Helmed By Biogen (BIIB) Alum Michael Gilman 2/28/2017
Buyers Remorse: Merck & Co. (MRK) Takes $2.9 Billion Charge on Hepatitis C Drug Inherited From $3.9 Billion Idenix (IDIX) Buy 2/27/2017
6 Biotechs Set Up Shop and Create Jobs in Buffalo, New York 2/27/2017
Roche (RHHBY) Reports Death in Phase III Hemophilia Study 2/27/2017
Ohr Pharma (OHRP) Suspends Work at San Diego Lab 2/27/2017
Surprising Departure: Celgene (CELG) President and COO "Retiring" in the Summer 2/27/2017
Future Biotech Giants: 11 Life Science Entrepreneurs Under 30 2/24/2017
50+ Valeant (VRX) Sales Reps May Have Jumped Ship to Synergy Pharma (SGYP) 2/24/2017
Serial Biotech Entrepreneur to Helm Biotech Startup FogPharma After Retiring From Harvard 2/24/2017
Why This 11-Employee Massachusetts Biotech's Market Cap Doubled Yesterday 2/24/2017
Backed by Johnson & Johnson (JNJ), Fusion Pharma Launches With $25 Million 2/24/2017
The End of the Road: New Jersey's NovaDel Pharma (NVD) to Dissolve 2/24/2017
This Drug Could Rattle Biogen (BIIB) and Be the Next Billion-Dollar Blockbuster for Celgene (CELG) 2/23/2017
2 Biotechs That Had a Rough 2016 But May Be Poised for a Turnaround This Year 2/23/2017
These Are the 4 Most Admired Life Science Companies in the World 2/23/2017
North Korean Biotech Institute Allegedly Involved in the Killing of Leader Kim Jong-Un's Half Brother 2/23/2017
Serial Investor Carl Icahn Takes Stake in Bristol-Myers Squibb (BMY), Stock Jumps 2/23/2017
Massachusetts' Agenus (AGEN) Quietly Discloses Failure of Cancer Vaccine Trial 2/22/2017
This Tiny Biotech Grew 412% in 2016. A Look at Whether It Can Continue in 2017 2/22/2017
Moderna's Oncology Boss Reportedly Leaving Company 2/22/2017
4 Biopharma Stocks a Billionaire Investor Just Bought 2/22/2017
Pfizer (PFE) Continues $190 Million Expansion Plans in North Carolina 2/22/2017
Why This UC Berkeley Scientist is Planning to Take on Washington in 2018 2/22/2017
Why ImmunoGen (IMGN) Investors are Waiting on Bated Breath to Move "FORWARD" 2/22/2017
Pfizer (PFE), Celgene (CELG), Eli Lilly (LLY), Merck & Co. (MRK) CEOs and Other Execs Send Letter Supporting GOP Tax Plan 2/22/2017
FDA Approval of Siliq for Psoriasis—How Will the Drug Perform in an Already Overcrowded Market? 2/22/2017
How Much Money Embattled Theranos Has Left in the Bank 2/21/2017
Rumored Acquisition Target Bristol-Myers Squibb (BMY) Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback 2/21/2017
5 Best U.S. Regions for Life Science Jobs 2/21/2017
Meet the Professor Who Was the First to Question Theranos' Research 2/21/2017
The 10 Biggest Losers in Biopharma Last Year 2/21/2017
Zoning Changes Kills Sale of Bristol-Myers Squibb (BMY)'s Connecticut Campus 2/21/2017
What This Contender for FDA's Top Job Could Do His First 6 Months on the Gig 2/21/2017
Why Startup Cue BioPharma Picked Daniel Passeri as Its New CEO 2/21/2017
There Are Hints That Depomed (DEPO)’s Boss’s Days Are Numbered 2/21/2017
Six Ways to Drastically Improve Your Company’s Employment Brand 2/21/2017
Norwegian Biotech Upstart Has Become a Potential Takeover Target 2/21/2017
Sarepta (SRPT) Auctions Off Its Priority Review Voucher for Exondys 51 to Gilead (GILD) for $125 Million 2/21/2017
Swiss Biotech Santhera (SANN.SW) Opens Up 20 Employee Shop in Massachusetts, Has Plans to Grow 2/20/2017
Questions Arise Over a Congressman's Ties With Australian Biotech Innate Immunotherapeutics 2/20/2017
3 Biotechs With the Biggest and Most Promising Pipelines 2/20/2017
Here Are 5 Tricky Job Interview Questions You Might Get at Genentech (RHHBY), Regeneron (REGN), and Stratos 2/20/2017
AstraZeneca PLC (AZN) Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial 2/20/2017
After Merck & Co. (MRK) & Eli Lilly (LLY) Alzheimer’s Failures, A Look at 7 Companies Still on the Hunt 2/20/2017
Woman to Watch: Meet the Woman Who is Helming Boston's Cocoon Biotech 2/20/2017
A Look at Whether AbbVie (ABBV) Could Eventually Face the Same Issues as Gilead (GILD) 2/17/2017
AMAG (AMAG) to Hire 150 New Sales Reps to Support New Drug Intrarosa 2/17/2017



//-->